Paul R. Edick - Director at Vistagen Therapeutics, Inc.

Issuer-level insider activity

Role: Director
Issuer ticker: VTGN on Nasdaq
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by Paul R. Edick since 06 Oct 2025

Reported holdings for Paul R. Edick in Vistagen Therapeutics, Inc.

Form 4 holding Director

Vistagen Therapeutics, Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 35,200
Estimated value
Report date: 27 Oct 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Transaction history for Paul R. Edick in Vistagen Therapeutics, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .